| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2008 | EP1891201A2 Pharmacokinetic-based culture system with biological barriers |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891108A1 Psp94 diagnostic reagents and assays |
| 02/27/2008 | EP1890708A1 Glucose inducible insulin expression and methods of treating diabetes |
| 02/27/2008 | EP1670897A4 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 02/27/2008 | EP1501452A4 Injectable chondrocyte implant |
| 02/27/2008 | EP1438393B1 Differentiation of whole bone marrow |
| 02/27/2008 | EP1344821B9 Novel aggrecanase |
| 02/27/2008 | EP1323732B9 Beta-catenin nuclear localizing protein |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1071714B1 A novel g-protein coupled receptor |
| 02/27/2008 | EP0942968B1 Fully human antibodies that bind EGFR |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133327A Stem cells, method for their purification, identification, and use |
| 02/27/2008 | CN101133158A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use |
| 02/27/2008 | CN101133074A RNAi modulation of APOB and uses thereof |
| 02/27/2008 | CN101132803A Tissue engineering edible meat and method of manufacturing the same |
| 02/27/2008 | CN101132694A Medical device with coating for capturing genetically-altered cells and methods of using same |
| 02/27/2008 | CN101130783A High-efficiency agrobacterium genetic transformation method for heavy metal super-enriched plant Indian mustard |
| 02/27/2008 | CN101130765A Reagent kit for detecting syncytial virus of respiratory passage |
| 02/27/2008 | CN101130764A Method and device for producing biological siliceous material with reactor culture sponge or its cell |
| 02/27/2008 | CN101130763A Rapid breeding method for gingkgo callus or suspending cell |
| 02/27/2008 | CN101129405A Biology formulated product for treating habitual abortion |
| 02/27/2008 | CN101129131A Non-asepsis seedling re-cutting seedling-producing method of hippeastrum |
| 02/27/2008 | CN101129130A Test tube flowering method of Chinese rose |
| 02/27/2008 | CN100371031C Materials and methods for augmenting and/or repairing intervertebral discs |
| 02/26/2008 | US7335828 Maize hybrid variety 39B63 |
| 02/26/2008 | US7335827 Plants and seeds of corn variety LH390 |
| 02/26/2008 | US7335826 Plants and seeds of corn variety I286375 |
| 02/26/2008 | US7335825 Inbred corn line PHF1J |
| 02/26/2008 | US7335824 Inbred corn line PHEJW |
| 02/26/2008 | US7335823 Inbred corn line PHE67 |
| 02/26/2008 | US7335822 Plants and seeds of corn variety I211986 |
| 02/26/2008 | US7335820 Soybean cultivar S06-M03256 |
| 02/26/2008 | US7335815 Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 02/26/2008 | US7335814 Transgenic cells expressing glucosyltransferase nucleic acids |
| 02/26/2008 | US7335811 Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells |
| 02/26/2008 | US7335764 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding acyl CoA cholesterol acyltransferase-2 that hybridizes with and inhibits the expression; treating atherosclerosis, cardiovascular disorders or metabolism disorders |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335750 Hybrid compositions for intracellular targeting |
| 02/26/2008 | US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 02/26/2008 | US7335745 Vectors with DNA encoding pro polypeptides |
| 02/26/2008 | US7335741 Diagnosis of lympghomas using nucleic acids; antigen binding zones |
| 02/26/2008 | US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders |
| 02/26/2008 | US7335735 Intracellular estradiol binding protein (IEBP) for use as tool in identifying modulator for treatment and prevention of bone and cell proliferative disorders |
| 02/26/2008 | US7335733 Tissue cement proteins from Rhipicephalus appendiculatus |
| 02/26/2008 | US7335732 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335731 PRO4332 polypeptides |
| 02/26/2008 | US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335729 PRO4320 polypeptide |
| 02/26/2008 | US7335646 Compositions and methods for regulated protein expression in gut |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335508 Lyophilized biomatrix comprising plasma proteins and thrombin; for medical applications including guided tissue repair and regeneration |
| 02/26/2008 | US7335507 Process for the staining of sperm |
| 02/26/2008 | US7335505 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/26/2008 | US7335502 Protein comprising an amino acid sequence having a chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase activity; stereoselectivity ; can produce an optically active compound with an industrial scale by using microorganisms with the gene |
| 02/26/2008 | US7335501 Derived from fungi of the Penicillium genus; vectors and transformed host organisms containing these polynucleotides encoding the phytases |
| 02/26/2008 | US7335492 Process for partitioning of proteins |
| 02/26/2008 | US7335489 Polynucleotides encoding a protein kinase C inhibitor protein and methods of using these polynucleotides |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335475 nucleotide sequences coding tumor suppressor (PR/SET) polypeptides for diagnosis, prognosis and treatment of cell proliferative disorders; anticarcinogenic agents; tumor suppressor genes |
| 02/26/2008 | US7335471 Polypeptides derived from RNA polymerases and use thereof |
| 02/26/2008 | US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus |
| 02/26/2008 | US7335364 Modified Vaccinia Ankara virus variant |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/26/2008 | US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 02/26/2008 | US7335230 Connective tissue substitutes, method of preparation and uses thereof |
| 02/26/2008 | CA2369590C Sodium/proton antiporter gene |
| 02/26/2008 | CA2351722C Mast cell-specific signal transducer and cdna thereof |
| 02/26/2008 | CA2260366C Recombinant n-proteinase, and the production, methods and uses thereof |
| 02/26/2008 | CA2071010C Modification of starch production |
| 02/22/2008 | CA2556855A1 Composition and method for enhancing plant transformation and homologous recombination |
| 02/21/2008 | WO2008021543A2 Transgenic plants with enhanced agronomic traits |
| 02/21/2008 | WO2008021502A2 Methods and compositions for removing cells from collection material |
| 02/21/2008 | WO2008021419A2 Nucleic acid quantitation from tissue slides |
| 02/21/2008 | WO2008021237A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 02/21/2008 | WO2008021196A2 Methods and compositions for the treatment of medical disorders |
| 02/21/2008 | WO2008021140A2 Recombinant aav production in mammalian cells |
| 02/21/2008 | WO2008021071A2 Substrates, devices, and methods for cellular assays |
| 02/21/2008 | WO2008020815A1 Mesenchymal stem cell conditioned medium |
| 02/21/2008 | WO2008020675A1 Method for co-culture of stem cells and feeder cells using polymer membrane |
| 02/21/2008 | WO2008020666A1 Embryonic stem cell-like cells |
| 02/21/2008 | WO2008020657A1 Acquired pluripotency through ovarian niche |
| 02/21/2008 | WO2008020645A1 Early-maturing transformed plant |
| 02/21/2008 | WO2008020595A1 Novel method for utilization of microbial mutant |
| 02/21/2008 | WO2008020586A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 02/21/2008 | WO2008020119A1 Activated fibroblasts for treating tissue and/or organ damage |
| 02/21/2008 | WO2008019573A1 Devices and methods for the adhesion of multiple types of cells onto the same substrate |
| 02/21/2008 | WO2008002400A3 Methods for altering cellular susceptibility to infection |
| 02/21/2008 | WO2007143451A3 Targeted delivery of oncolytic viruses, anti-tumor proteins, plasmids, toxins, hemolysins & chemotherapy |
| 02/21/2008 | WO2007138143A3 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products |
| 02/21/2008 | WO2007136424A3 Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates |
| 02/21/2008 | WO2007129770A3 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof |
| 02/21/2008 | WO2007128496A3 A group of esterases for the enantioselective production of fine and speciality chemicals |
| 02/21/2008 | WO2007103177A3 Manipulation of oxygen tension during in vitro follicle culture |
| 02/21/2008 | WO2007102812A9 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells |
| 02/21/2008 | WO2007011941A9 Human anti-b7rp1 neutralizing antibodies |
| 02/21/2008 | US20080047037 the polypeptides have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or a high-glucose syrup or a mixed syrup, for liquifying a starch-comprising composition |
| 02/21/2008 | US20080047036 Plant transformation method |
| 02/21/2008 | US20080047035 Plasmid which utilizes recombination for efficient genic transfer into host genomes; genetic engineering |